Dimenhydrinate - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for dimenhydrinate and what is the scope of freedom to operate?
Dimenhydrinate
is the generic ingredient in one branded drug marketed by Baxter Hlthcare, Fresenius Kabi Usa, Watson Labs, Watson Labs Teva, Wyeth Ayerst, Alra, Heather, and Nexgen Pharma Inc, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.There are five drug master file entries for dimenhydrinate. One supplier is listed for this compound.
Summary for dimenhydrinate
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 8 |
NDAs: | 9 |
Drug Master File Entries: | 5 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 72 |
Clinical Trials: | 20 |
Patent Applications: | 6,664 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price trends for dimenhydrinate |
What excipients (inactive ingredients) are in dimenhydrinate? | dimenhydrinate excipients list |
DailyMed Link: | dimenhydrinate at DailyMed |
Recent Clinical Trials for dimenhydrinate
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Ciusss de L'Est de l'Île de Montréal | N/A |
IWK Health Centre | Phase 4 |
University of British Columbia | Phase 2/Phase 3 |
Medical Subject Heading (MeSH) Categories for dimenhydrinate
US Patents and Regulatory Information for dimenhydrinate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Wyeth Ayerst | DIMENHYDRINATE | dimenhydrinate | INJECTABLE;INJECTION | 084316-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Watson Labs Teva | DIMENHYDRINATE | dimenhydrinate | INJECTABLE;INJECTION | 080615-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Alra | DIMENHYDRINATE | dimenhydrinate | LIQUID;ORAL | 080715-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Heather | DIMENHYDRINATE | dimenhydrinate | TABLET;ORAL | 080841-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Fresenius Kabi Usa | DIMENHYDRINATE | dimenhydrinate | INJECTABLE;INJECTION | 040519-001 | Jun 23, 2004 | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Watson Labs | DIMENHYDRINATE | dimenhydrinate | INJECTABLE;INJECTION | 083531-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Watson Labs | DIMENHYDRINATE | dimenhydrinate | TABLET;ORAL | 085166-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |